| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/28/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 273.6k | $7.54 | $2.1M | See footnote | 07/16/2020 |
| 09/25/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 174.2k | $7.08 | $1.2M | See footnote | 07/16/2020 |
| 09/24/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 38.5k | $7.63 | $293.8k | See footnote | 07/16/2020 |
| 08/13/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 159 | $8.75 | $1.4k | See footnote | 07/16/2020 |
| 08/12/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 1.3k | $8.79 | $11.7k | See footnote | 07/16/2020 |
| 07/29/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 2.7k | $8.78 | $23.8k | See footnote | 07/16/2020 |
| 07/22/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 22.7k | $9.00 | $203.9k | See footnote | 07/16/2020 |
| 07/20/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 37k | $9.25 | $342.1k | See footnote | 07/16/2020 |
| 07/17/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 31.1k | $9.24 | $287.4k | See footnote | 07/16/2020 |
| 07/16/2020 | LogicBio Therapeutics, Inc. | LOGC | Sale | Common stock | 16.3k | $8.56 | $139.8k | See footnote | 07/16/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 366.6k | $21.33 | $7.8M | See Footnote | 05/27/2020 |
| 05/27/2020 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 12.1k | $22.39 | $270.1k | See Footnote | 05/27/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series B Preferred Stock | 8.6M | $0.00 | $0 | By entities affiliated with Arix Bioscience plc | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 187.5k | $16.00 | $3M | By entities affiliated with Arix Bioscience plc | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 1.4M | $0.00 | $0 | By entities affiliated with Arix Bioscience plc | 03/16/2020 |
| 12/17/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 12.5k | $16.83 | $210k | See Footnote | 12/13/2019 |
| 12/16/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 13.1k | $17.02 | $222.7k | See Footnote | 12/13/2019 |
| 12/13/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 11k | $17.21 | $189.3k | See Footnote | 12/13/2019 |
| 12/10/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 131.7k | $16.91 | $2.2M | See Footnote | 12/06/2019 |
| 12/09/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 26.4k | $18.30 | $483.8k | See Footnote | 12/06/2019 |
| 12/09/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 77.3k | $18.12 | $1.4M | See Footnote | 12/06/2019 |
| 12/06/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common stock | 47.8k | $19.15 | $914.2k | See Footnote | 12/06/2019 |
| 02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Common stock | 2.5M | $0.00 | $0 | See Footnote | 02/12/2019 |
| 02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common stock | 428.6k | $14.00 | $6M | See Footnote | 02/12/2019 |
| 02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Series B Convertible Preferred Stock | 1.7M | $0.00 | $0 | See Footnote | 02/12/2019 |
| 02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Series C Convertible Preferred Stock | 742.8k | $0.00 | $0 | See Footnote | 02/12/2019 |
| 10/23/2018 | LogicBio Therapeutics, Inc. | LOGC | Conversion | Common stock | 2.3M | $0.00 | $0 | See Footnote | 10/23/2018 |
| 10/23/2018 | LogicBio Therapeutics, Inc. | LOGC | Purchase | Common stock | 700k | $10.00 | $7M | See Footnote | 10/23/2018 |
| 10/23/2018 | LogicBio Therapeutics, Inc. | LOGC | Conversion | Series B Preferred Stock | 4.4M | $0.00 | $0 | See Footnote | 10/23/2018 |